Skip to main content

Table 6 Univariate and multivariate Cox hazard analyses of the risk factors for survival after diagnosis of PE

From: Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China

 

Univariate analysis

Multivariate analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

Age ≥ 70 y

1.818 (1.116–2.962)

0.016*

2.487 (1.487–4.161)

0.001*

Female sex

1.038 (0.690–1.562)

0.857

  

Stage IV disease

2.028 (1.165–3.531)

0.012*

2.024 (1.131–3.623)

0.018*

SPE

1.823 (1.200–2.768)

0.005*

1.564 (1.008–2.425)

0.046*

Central or lobar location

0.808 (0.520–1.254)

0.342

  

Central, lobar, or segmental location

0.919 (0.599–1.411)

0.700

  

Multiple

1.578 (0.908–2.745)

0.106

  

Bilateral

1.203 (0.793–1.823)

0.385

  

Combined with DVT

1.184 (0.787–1.781)

0.418

  

ECOG PS > 1

2.784 (1.821–4.258)

< 0.001*

2.276 (1.429–3.626)

0.001*

Low BMI

1.329 (0.539–3.278)

0.537

  

Overweight

0.663 (0.441–0.997)

0.048*

0.896 (0.590–1.359)

0.604

Obesity

0.687 (0.374–1.262)

0.226

  

Anticoagulation therapy

0.834 (0.515–1.353)

0.463

  

Thrombolytic therapy

3.762 (1.342–10.545)

0.012*

5.208 (1.801–15.063)

0.002*

Filter implantation

0.654 (0.286–1.497)

0.315

  

Bleeding event

0.909 (0.468–1.765)

0.778

  
  1. PE, pulmonary embolism; HR, hazard ratio; CI, confidence interval; SPE, symptomatic pulmonary embolism; DVT, deep vein thrombosis; ECOG PS, Eastern Cooperative Oncology Group performance status; BMI, body mass index; * means P < 0.05